Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market sale 10% owner sold 2,829,314 shares at an average $0.53 ($1,488,844)
  2. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,850 shares at $1.30 ($3,705)
  3. 4 Open-market sale Brazzell Romulus K sold 3,504 shares at $1.30 ($4,555)
  4. 4 Open-market sale Bazemore Todd sold 3,454 shares at $1.30 ($4,490)
  5. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 9,518 shares at $1.30 ($12,373)
  6. 4 Open-market sale Trachtenberg Eric sold 2,850 shares at $1.30 ($3,705)
  7. 4 Grant or award CHIEF BUSINESS OFFICER acquired 295,657 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 5,341,120 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 30,500 shares at an average $1.81 ($55,321)
  12. 4 Open-market sale Trachtenberg Eric sold 9,449 shares at $1.80 ($17,008)
  13. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 9,449 shares at $1.80 ($17,008)
  14. 4 Open-market sale CHIEF OPERATING OFFICER sold 12,544 shares at $1.80 ($22,579)
  15. 4 Open-market sale CHIEF MEDICAL OFFICER sold 12,757 shares at $1.80 ($22,963)
  16. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 27,598 shares at $1.80 ($49,676)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 5,548 shares at $5.56 ($30,847)
  20. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,452 shares at $5.77 ($14,148)

Page 7 of 15 · 288 filings